Chung, D. Y., Kang, D. H., Kim, J. W., Ha, J. S., Kim, D. K., & Cho, K. S. (2021). Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis. Cancers (Basel).
Citação norma ChicagoChung, Doo Yong, Dong Hyuk Kang, Jong Won Kim, Jee Soo Ha, Do Kyung Kim, and Kang Su Cho. "Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) With Gemcitabine and Cisplatin (GC) As Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis." Cancers (Basel) 2021.
Citação norma MLAChung, Doo Yong, et al. "Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) With Gemcitabine and Cisplatin (GC) As Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis." Cancers (Basel) 2021.